National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
75.30
-0.08 (-0.11%)
Aug 7, 2026, 4:00 PM EDT - Market closed
National Health Investors Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,650 | 3,689 | 3,166 | 2,424 | 2,266 | 2,635 | |
Market Cap Growth | 5.73% | 16.51% | 30.59% | 7.00% | -14.01% | -15.69% |
Enterprise Value | 4,895 | 4,851 | 4,307 | 3,557 | 2,565 | 2,951 |
Last Close Price | 75.30 | 76.37 | 69.30 | 55.85 | 52.22 | 57.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.29 | 25.29 | 22.14 | 17.84 | 35.28 | 23.55 |
PS Ratio | 9.02 | 9.82 | 9.45 | 7.58 | 8.14 | 19.05 |
PB Ratio | 2.41 | 2.42 | 2.32 | 1.93 | - | - |
P/TBV Ratio | 2.37 | 2.36 | 2.24 | 1.93 | - | - |
P/FCF Ratio | - | - | 63.53 | 17.97 | 13.00 | - |
P/OCF Ratio | 14.99 | 15.59 | 15.24 | 13.14 | 12.22 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.09 | 12.92 | 12.85 | 11.12 | 9.22 | 21.33 |
EV/EBITDA Ratio | 17.06 | 17.46 | 16.72 | 14.25 | 16.06 | - |
EV/EBIT Ratio | 24.65 | 25.00 | 23.51 | 20.08 | 31.57 | - |
EV/FCF Ratio | - | - | 86.41 | 26.37 | 14.71 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.83 | 0.76 | 0.83 | 0.90 | - | - |
Debt / EBITDA Ratio | 4.43 | 4.19 | 4.45 | 4.55 | 1.89 | - |
Debt / FCF Ratio | - | - | 23.00 | 8.41 | 1.73 | - |
Net Debt / Equity Ratio | 0.82 | 0.75 | 0.82 | 0.89 | - | - |
Net Debt / EBITDA Ratio | 4.34 | 4.12 | 4.36 | 4.46 | 1.87 | -63.47 |
Net Debt / FCF Ratio | -18.69 | -19.91 | 22.51 | 8.25 | 1.72 | -8.42 |
Asset Turnover | 0.14 | 0.14 | 0.13 | 0.22 | 0.68 | 0.08 |
Quick Ratio | 2.75 | 2.25 | 2.95 | 3.12 | 0.10 | 0.09 |
Current Ratio | 2.75 | 2.25 | 2.95 | 3.12 | 0.17 | 0.17 |
Return on Equity (ROE) | 9.61% | 9.69% | 10.35% | 21.26% | - | -2.79% |
Return on Assets (ROA) | 6.98% | 7.17% | 7.18% | 12.26% | 19.81% | -1.13% |
Return on Invested Capital (ROIC) | 7.30% | 7.51% | 7.52% | 7.45% | - | - |
Return on Capital Employed (ROCE) | 7.08% | 7.28% | 7.28% | 12.71% | 23.51% | -1.16% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.05% | 3.95% | 4.52% | 5.60% | 2.83% | 4.25% |
FCF Yield | - | - | 1.57% | 5.56% | 7.69% | - |
Dividend Yield | 4.89% | 4.74% | 5.15% | 6.45% | 6.92% | 0.00% |
Payout Ratio | 118.69% | 119.52% | 113.52% | 115.22% | 243.62% | 0.00% |
Buyback Yield / Dilution | -6.72% | -6.69% | -1.64% | 3.14% | 2.05% | -2.31% |
Total Shareholder Return | -1.83% | -1.95% | 3.51% | 9.58% | 8.96% | -2.31% |